Literature DB >> 8816156

Emergence of resistance to amphotericin B during therapy for Candida glabrata infection in an immunocompetent host.

T R Sterling1, R A Gasser, A Ziegler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8816156     DOI： 10.1093/clinids/23.1.187

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  8 in total

Review 1.  Antifungal susceptibility testing: practical aspects and current challenges.

Authors:  J H Rex; M A Pfaller; T J Walsh; V Chaturvedi; A Espinel-Ingroff; M A Ghannoum; L L Gosey; F C Odds; M G Rinaldi; D J Sheehan; D W Warnock
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

Review 2.  Epidemiology of invasive candidiasis: a persistent public health problem.

Authors:  M A Pfaller; D J Diekema
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

3.  Comparison of the in vitro activities of the echinocandin LY303366, the pneumocandin MK-0991, and fluconazole against Candida species and Cryptococcus neoformans.

Authors:  T V Krishnarao; J N Galgiani
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

4.  Evaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcome.

Authors:  Benjamin J Park; Beth A Arthington-Skaggs; Rana A Hajjeh; Naureen Iqbal; Meral A Ciblak; Wendy Lee-Yang; Mario D Hairston; Maureen Phelan; Brian D Plikaytis; Andre N Sofair; Lee H Harrison; Scott K Fridkin; David W Warnock
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

5.  Improved detection of amphotericin B-resistant isolates of Candida lusitaniae by Etest.

Authors:  F Peyron; A Favel; A Michel-Nguyen; M Gilly; P Regli; A Bolmström
Journal:  J Clin Microbiol       Date:  2001-01       Impact factor: 5.948

6.  In vivo efficacy of anidulafungin and caspofungin against Candida glabrata and association with in vitro potency in the presence of sera.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; Destiny Molina; Marcos Olivo; John R Graybill
Journal:  Antimicrob Agents Chemother       Date:  2007-02-16       Impact factor: 5.191

7.  Relationship between susceptibility of Candida spp. isolates to amphotericin B and death or survival of patients with candidemia episodes.

Authors:  Sydney Hartz Alves; Everton Boff; Patricia Pozzatti; Liliane A Scheid; Erico de Loreto; Loiva T Ottoneli Oliveira; Valério Aquino; Luiz Carlos Severo; Janio Morais Santurio
Journal:  Mycopathologia       Date:  2008-09-26       Impact factor: 2.574

8.  Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.

Authors:  J A Vazquez; M T Arganoza; D Boikov; S Yoon; J D Sobel; R A Akins
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.